The genetic regulation of protein expression in cerebrospinal fluid is a research paper published in EMBO Molecular Medicine (2022). On theSindex it has a DataRank of 0.604. It has been cited 55 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.604
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Alzheimer Drug Discovery Foundation
Grant: RDAPB‐201809‐2016615
European Research Council
Grant: 681712
European Union Joint Program for Neurodegenerative Disorders
Grant: JPND2021‐00694
European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement
Grant: 860197
Hjärnfonden
Grant: FO2017‐0243
Hjärnfonden
Grant: FO2019‐0228
Knut and Alice Wallenberg Foundation
Grant: 2017‐0383
Knut and Alice Wallenberg Foundation
Grant: WCMM 2019
Regionalt Forskningsstöd
Grant: 2020‐0314
Stiftelsen Gamla Tjänarinnor
Grant: 2019‐00845
Swedish Alzheimer Foundation
Grant: AF‐939932
Swedish Alzheimer Foundation
Grant: AF‐930655
Swedish Alzheimer Foundation
Grant: AF‐968453
Swedish Alzheimer Foundation
Grant: AF‐742881
Swedish Research Council
Grant: 2018‐02532
Swedish State Support for Clinical Research
Grant: ALFGBG‐720931
Swedish state under the agreement between the Swedish government and the County Councils, the ALF‐agreement
Grant: ALFGBG‐715986
the AD Strategic Fund and the Alzheimer's Association
Grant: ADSF‐21‐831376‐C
the Alzheimer Drug Discovery Foundation
Grant: 201809‐2016862
the Alzheimer's Association 2021 Zenith Award
Grant: ZEN‐21‐848495
the European Union Joint Program for Neurodegenerative Disorders
Grant: JPND2019‐466‐236
the Marianne and Marcus Wallenberg foundation
Grant: 2015.0125
the National Institute of Health
Grant: 1R01AG068398‐01
The Parkinson foundation of Sweden
Grant: 1280/20
the Skåne University Hospital Foundation
Grant: 2020‐O000028
the Swedish Brain Foundation
Grant: FO2021‐0293
the Swedish Brain Foundation
Grant: FO2019‐0029
the Swedish Brain Foundation
Grant: FO2020‐0275
the Swedish federal government under the ALF agreement
Grant: 2018‐Projekt0279
the Swedish federal government under the ALF agreement
Grant: 2018‐Projekt0054
Vetenskapsrådet
Grant: 2021‐02219
Vetenskapsrådet
Grant: 2016‐00906
Vetenskapsrådet
Grant: 2017‐00915
NIA NIH HHS
Grant: P30 AG010161
NIA NIH HHS
Grant: P50 AG016574
NIMH NIH HHS
Grant: P50 MH066392
NIMH NIH HHS
Grant: R01 MH097276
NIA NIH HHS
Grant: U01 AG006786
NIA NIH HHS
Grant: R01 AG018023
NIA NIH HHS
Grant: U01 AG046139
NIA NIH HHS
Grant: R01 AG015819
NIA NIH HHS
Grant: R01 AG036836
NIMH NIH HHS
Grant: R01 MH109897
NIMH NIH HHS
Grant: R37 MH057881
NIA NIH HHS
Grant: P30 AG019610
NIA NIH HHS
Grant: P50 AG005138
NIA NIH HHS
Grant: R01 AG017917
NIMH NIH HHS
Grant: R01 MH093725
NIA NIH HHS
Grant: U01 AG046152
NIDA NIH HHS
Grant: HHSN271201300031C
NIMH NIH HHS
Grant: P50 MH084053
NIMH NIH HHS
Grant: R01 MH085542
NIMH NIH HHS
Grant: R01 MH109677
NIA NIH HHS
Grant: R01 AG032990
NIA NIH HHS
Grant: R01 AG048015
NIMH NIH HHS
Grant: R01 MH080405
NIMH NIH HHS
Grant: U01 MH103392
NIA NIH HHS
Grant: P01 AG002219
NIA NIH HHS
Grant: P01 AG017216
NINDS NIH HHS
Grant: R01 NS080820
NINDS NIH HHS
Grant: U24 NS072026
NIA NIH HHS
Grant: P01 AG003949
NIA NIH HHS
Grant: P50 AG025711
NIA NIH HHS
Grant: R01 AG068398
NIMH NIH HHS
Grant: R01 MH110921
The Bundy Academy
Erling‐Persson Family Foundation
Strategic Research Area MultiPark
Olav Thon Foundation
Stiftelsen för Gamla Tjänarinnor
UK Dementia Research Institute at UCL
the Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
FWCI
5.48
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)
Additional file 1 of Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)
Additional file 2 of Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)
Additional file 2 of Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)
Additional file 1 of Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
Additional file 1 of Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
Additional file 2 of Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
Additional file 2 of Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology